ALLMedicine™ Hepatitis B Virus Center
Research & Reviews 17,881 results
https://doi.org/10.1002/hep.31890
Hepatology (Baltimore, Md.); Yip TC, Wong VW et. al.
May 7th, 2021 - We compared risk of acute liver injury and mortality in COVID-19 patients with current, past, and no hepatitis B virus (HBV) infection. This was a territory-wide retrospective cohort study in Hong Kong. COVID-19 patients between 23 January 2020 an...
https://doi.org/10.1007/s12328-021-01423-5 10.1016/S0140-6736(15)61412-X 10.1002/hep.23327 10.1002/hep.22841 10.1002/hep.26686 10.1016/S2468-1253(16)30024-3 10.1016/S2468-1253(16)30107-8 10.1002/hep.1840070416 10.1159/000490099 10.4254/wjh.v5.i7.387 10.1055/s-0033-1345722 10.1002/jmv.24115 10.1007/s00705-010-0628-x 10.1128/JVI.64.3.1298-1303.1990 10.1016/j.jcv.2012.06.011 10.2957/kanzo.47.279 10.1053/jhep.2001.28708 10.1002/jmv.25730 10.1186/1743-422X-11-9 10.1097/00007890-200207270-00007 10.1007/s12185-009-0359-5 10.1002/hep.21249 10.1136/gut.52.11.1630 10.1111/j.1872-034X.2009.00519.x 10.1016/j.virusres.2016.04.022 10.1016/j.virusres.2010.10.013 10.1016/j.virusres.2012.02.013 10.1128/JVI.00661-06 10.1093/carcin/bgn111 10.1002/hep.29800 10.2169/internalmedicine.5678-20
Clinical Journal of Gastroenterology; Takakusagi S, Takagi H et. al.
May 7th, 2021 - A 76-year-old woman with spontaneous reactivation of hepatitis B virus (HBV) without any immunosuppressants who had been successfully treated with tenofovir alafenamide fumarate (TAF) was reported. The patient was admitted to our hospital because ...
https://doi.org/10.1016/j.jhep.2021.04.040
Journal of Hepatology; Berg T, Lampertico P
May 6th, 2021 - Although discontinuation of nucleos(t)ide analogue (NA) treatment before HBsAg loss is part of all current hepatitis B virus (HBV) treatment guidelines for HBeAg-positive patients who achieved HBeAg seroconversion, a treatment endpoint known to be...
https://doi.org/10.1111/trf.16431
Transfusion De Brier N, Koc ÖM et. al.
May 6th, 2021 - Transfusion-transmissible infections such as hepatitis B virus (HBV) remain a major concern for the safety of blood transfusion. This cross-sectional study aimed to assess the trend of HBV prevalence and associated risk factors among a first-time ...
https://doi.org/10.1158/1078-0432.CCR-21-0002
Clinical Cancer Research : an Official Journal of the Ame... Zheng B, Liu X et. al.
May 5th, 2021 - Intratumoral hepatitis B virus (HBV) integrations and mutations are related to hepatocellular carcinoma (HCC) progression. Circulating cell-free DNA (cfDNA) has shown itself as a powerful non-invasive biomarker for cancer. However, the HBV integra...
Guidelines 51 results
https://doi.org/10.1001/jama.2020.22980
JAMA , Krist AH et. al.
Dec 15th, 2020 - An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and part...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.
Jul 27th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP
Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.
Oct 15th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...
https://jamanetwork.com/journals/jama/fullarticle/2738558
JAMA
Jul 22nd, 2019 - Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100...
Drugs 21 results see all →
Clinicaltrials.gov 18,237 results
https://doi.org/10.1002/hep.31890
Hepatology (Baltimore, Md.); Yip TC, Wong VW et. al.
May 7th, 2021 - We compared risk of acute liver injury and mortality in COVID-19 patients with current, past, and no hepatitis B virus (HBV) infection. This was a territory-wide retrospective cohort study in Hong Kong. COVID-19 patients between 23 January 2020 an...
https://doi.org/10.1007/s12328-021-01423-5 10.1016/S0140-6736(15)61412-X 10.1002/hep.23327 10.1002/hep.22841 10.1002/hep.26686 10.1016/S2468-1253(16)30024-3 10.1016/S2468-1253(16)30107-8 10.1002/hep.1840070416 10.1159/000490099 10.4254/wjh.v5.i7.387 10.1055/s-0033-1345722 10.1002/jmv.24115 10.1007/s00705-010-0628-x 10.1128/JVI.64.3.1298-1303.1990 10.1016/j.jcv.2012.06.011 10.2957/kanzo.47.279 10.1053/jhep.2001.28708 10.1002/jmv.25730 10.1186/1743-422X-11-9 10.1097/00007890-200207270-00007 10.1007/s12185-009-0359-5 10.1002/hep.21249 10.1136/gut.52.11.1630 10.1111/j.1872-034X.2009.00519.x 10.1016/j.virusres.2016.04.022 10.1016/j.virusres.2010.10.013 10.1016/j.virusres.2012.02.013 10.1128/JVI.00661-06 10.1093/carcin/bgn111 10.1002/hep.29800 10.2169/internalmedicine.5678-20
Clinical Journal of Gastroenterology; Takakusagi S, Takagi H et. al.
May 7th, 2021 - A 76-year-old woman with spontaneous reactivation of hepatitis B virus (HBV) without any immunosuppressants who had been successfully treated with tenofovir alafenamide fumarate (TAF) was reported. The patient was admitted to our hospital because ...
https://doi.org/10.1016/j.jhep.2021.04.040
Journal of Hepatology; Berg T, Lampertico P
May 6th, 2021 - Although discontinuation of nucleos(t)ide analogue (NA) treatment before HBsAg loss is part of all current hepatitis B virus (HBV) treatment guidelines for HBeAg-positive patients who achieved HBeAg seroconversion, a treatment endpoint known to be...
https://doi.org/10.1111/trf.16431
Transfusion De Brier N, Koc ÖM et. al.
May 6th, 2021 - Transfusion-transmissible infections such as hepatitis B virus (HBV) remain a major concern for the safety of blood transfusion. This cross-sectional study aimed to assess the trend of HBV prevalence and associated risk factors among a first-time ...
https://doi.org/10.1158/1078-0432.CCR-21-0002
Clinical Cancer Research : an Official Journal of the Ame... Zheng B, Liu X et. al.
May 5th, 2021 - Intratumoral hepatitis B virus (HBV) integrations and mutations are related to hepatocellular carcinoma (HCC) progression. Circulating cell-free DNA (cfDNA) has shown itself as a powerful non-invasive biomarker for cancer. However, the HBV integra...
News 397 results
https://www.medscape.com/viewarticle/948611
Apr 1st, 2021 - These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed at the Gastroenterology Updates, IBD, Liver Disease Conference. That's because the t...
https://www.medscape.com/viewarticle/942681
Dec 15th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...
https://www.staging.medscape.com/viewarticle/936294
Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...
https://www.medscape.com/viewarticle/936294
Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...
https://www.medscape.com/viewarticle/935890
Aug 18th, 2020 - NEW YORK (Reuters Health) - In HIV/hepatitis B virus (HBV)-coinfected individuals with renal dysfunction, renal function improves after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), according to results from a ...
